Shares of KNE stock opened at C$0.07 on Wednesday. The firm has a market cap of $6.01, a PE ratio of -1.40 and a beta of 0.59. Kane Biotech has a 1 year low of C$0.07 and a 1 year high of C$0.18.
Kane Biotech Company Profile
Kane Biotech Inc is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company’s technologies include DispersinB, AloSera, Aledex, Strix NB, bluestem and KBI Disinfectant. It is focused on the companion animal market with Strix NB brand for the veterinary segment and bluestem brand for the pet over the counter (OTC) retail market.
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.